<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Forny P</submitter><funding>Swiss National Science Foundation</funding><pagination>80-95</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9886552</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(1)</volume><pubmed_abstract>Methylmalonic aciduria (MMA) is an inborn error of metabolism with multiple monogenic causes and a poorly understood pathogenesis, leading to the absence of effective causal treatments. Here we employ multi-layered omics profiling combined with biochemical and clinical features of individuals with MMA to reveal a molecular diagnosis for 177 out of 210 (84%) cases, the majority (148) of whom display pathogenic variants in methylmalonyl-CoA mutase (MMUT). Stratification of these data layers by disease severity shows dysregulation of the tricarboxylic acid cycle and its replenishment (anaplerosis) by glutamine. The relevance of these disturbances is evidenced by multi-organ metabolomics of a hemizygous Mmut mouse model as well as through identification of physical interactions between MMUT an</pubmed_abstract><journal>Nature metabolism</journal><pubmed_title>Integrated multi-omics reveals anaplerotic rewiring in methylmalonyl-CoA mutase deficiency.</pubmed_title><pmcid>PMC9886552</pmcid><funding_grant_id>175779</funding_grant_id><funding_grant_id>192505</funding_grant_id><funding_grant_id>211038</funding_grant_id><funding_grant_id>310030</funding_grant_id><pubmed_authors>Xenarios I</pubmed_authors><pubmed_authors>Ratsch G</pubmed_authors><pubmed_authors>Wollscheid B</pubmed_authors><pubmed_authors>Lamparter D</pubmed_authors><pubmed_authors>Howald C</pubmed_authors><pubmed_authors>Zamboni N</pubmed_authors><pubmed_authors>Shao W</pubmed_authors><pubmed_authors>Burer C</pubmed_authors><pubmed_authors>Harshman K</pubmed_authors><pubmed_authors>Frei C</pubmed_authors><pubmed_authors>Dermitzakis ET</pubmed_authors><pubmed_authors>Poms M</pubmed_authors><pubmed_authors>Cherkaoui S</pubmed_authors><pubmed_authors>Traversi F</pubmed_authors><pubmed_authors>Morscher RJ</pubmed_authors><pubmed_authors>Simmons L</pubmed_authors><pubmed_authors>Goetze S</pubmed_authors><pubmed_authors>Pedrioli PGA</pubmed_authors><pubmed_authors>van Drogen A</pubmed_authors><pubmed_authors>Baumgartner MR</pubmed_authors><pubmed_authors>Bingisser A</pubmed_authors><pubmed_authors>Bonilla X</pubmed_authors><pubmed_authors>Plessl T</pubmed_authors><pubmed_authors>Aebersold R</pubmed_authors><pubmed_authors>Froese DS</pubmed_authors><pubmed_authors>Forny M</pubmed_authors><pubmed_authors>Forny P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integrated multi-omics reveals anaplerotic rewiring in methylmalonyl-CoA mutase deficiency.</name><description>Methylmalonic aciduria (MMA) is an inborn error of metabolism with multiple monogenic causes and a poorly understood pathogenesis, leading to the absence of effective causal treatments. Here we employ multi-layered omics profiling combined with biochemical and clinical features of individuals with MMA to reveal a molecular diagnosis for 177 out of 210 (84%) cases, the majority (148) of whom display pathogenic variants in methylmalonyl-CoA mutase (MMUT). Stratification of these data layers by disease severity shows dysregulation of the tricarboxylic acid cycle and its replenishment (anaplerosis) by glutamine. The relevance of these disturbances is evidenced by multi-organ metabolomics of a hemizygous Mmut mouse model as well as through identification of physical interactions between MMUT an</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-10T06:51:33.818Z</modification><creation>2025-04-19T17:17:21.211Z</creation></dates><accession>S-EPMC9886552</accession><cross_references><pubmed>36717752</pubmed><doi>10.1038/s42255-022-00720-8</doi></cross_references></HashMap>